BBNX vs AORT
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
BBNX · Beta Bionics$15.70 ▲ 1.36%
AORT · Artivion$20.21 ▼ 20.21%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- BBNX -42.9%
- AORT -55.1%
Head to head
| Metric | BBNX | AORT |
|---|---|---|
| Price | $15.70 | $20.21 |
| Change today | ▲ 1.36% | ▼ 20.21% |
| Market cap | $853.56M | $986.05M |
| Return, 3 months | -4.3% | -23.2% |
| Return, year to date | -48.5% | -55.7% |
| Return, 1 year | -40.3% | -55.0% |
| P/E (TTM) | – | – |
| P/B | 2.1 | 2.2 |
| P/E percentile vs own 5y | 45th | 9th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +30.3% | +11.3% |
| Net profit growth (YoY) | -71.4% | -1,104.5% |
| Gross margin | 58.6% | 64.4% |
| Operating margin | -72.7% | 2.9% |
| Net margin | -65.3% | -0.7% |
| Return on equity | -23.9% | -0.7% |
| Analyst target vs. price | +61.5% | +99.5% |
| Analyst buy share | 75% | 100% |
| RSI (14) | 41 | 38 |
| 30-day volatility | 87.4% | 82.5% |
| Max drawdown, 1 year | -72.3% | -57.8% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- AORT is the largest of the group by market value.
- BBNX has returned the most over the past year.
- BBNX is growing revenue fastest.
- AORT keeps the most profit per dollar of sales.
- AORT has been the calmest stock over the last 30 days.